PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 9, 2008 Subscribe to this News Feed    
 

VisiVite.com Presents New Study Findings: Antioxidants Halt and Prevent Macular Degeneration

A New Study Published In Journal of Biological Chemistry Reasserts the Benefit of Antioxidants On Macular Degeneration and Traces a Link Between the Disease and Cell Damage Caused By Oxidation.

Huntington, NY (PRWEB) September 9, 2008 -- VisiVite.com, a market leader in eye health supplements to treat age-related macular degeneration, announces that a study published today in the Journal of Biological Chemistry once again confirms the benefits of antioxidants, including those in VisiVite supplements, in the treatment of age-related macular degeneration, also known as AMD.

Conducted jointly by Brigham Young University and Cornell University, the study finds that antioxidants - molecules that prevent the reactions that create harmful free radicals - can not only halt macular degeneration, but may be able to prevent the disease in individuals at risk for it.

Although little conclusive information exists about the root cause of macular degeneration, the study's results indicate a correlation between vision loss and oxidative cell damage. Treatment with antioxidants and other alternative therapies have been shown to slow the disease's onset, but the non-replicating cells in the human eye cannot repair any existing damage, leading researchers to theorize that gene therapy and stem cell research may hold the secret to reversing the damage.

Macular degeneration affects more than 10 million Americans, and is the leading cause of blindness in the United States for individuals over the age of 55. The condition is caused by thinning of the macula, or the lining of the retina, which in turn causes the progressive loss of central vision.

The BYU-Cornell study evaluated the effects of trolox, a vitamin E derivative antioxidant, on vision cells from rats, cows and humans.

VisiVite.com manufactures macular degeneration vitamin supplements with antioxidants like Lutein, Zeaxanthin, Vitamin E and beta-carotene to help individuals with AMD, or those at risk for AMD, to delay or stop the progress of central vision loss.

About VisiVite.com:
Since 2001, VisiVite.com is dedicated to providing customers with state of the art macular degeneration vitamins to lessen the risk of age-related macular degeneration. Their products include several VisiVite Omega-3 eye supplements, Macular Degeneration Vitamins and Dry Eye Relief Vitamins. For more information and up-to-the minute AMD news, visit VisiVite.com.

Contact:
VisiVite.com
1-800-427-7660
http://www.visivite.com

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
PAUL KRAWITZ
VisiVite
1-800-427-7660
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.